Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Needham's latest Semicap Tracker, its 33rd edition, incorporates July equipment import data for Korea, Taiwan and China, updated global semiconductor sales through June, and memory spot prices through August 21. The report highlights an accelerating sales cycle led by memory, stronger wafer fabrication equipment flows into China, Taiwan and Korea, …
Futures for the S&P 500 and Nasdaq eased on Friday following a technology-led advance driven by Nvidia’s upbeat outlook the day before. Markets were focused on Federal Reserve Chair Kevin Warsh’s first speech at the central bank’s annual Jackson Hole symposium, seeking any guidance on how policy-makers might respond to mixed inflation readings and …
A small but growing cohort of small businesses is experimenting with prediction market platforms to protect against narrowly defined financial risks tied to promotions, labor rules and commodity-linked costs. Trading firms, a market operator and a specialty finance startup have collaborated to craft event contracts that pay out when specified outco…
Didi Global says it will invest more than $200 million in Argentina this year to expand into smaller towns, introduce new transport options such as motorcycle rides and last-mile services, and develop safety-related mapping and AI capabilities. The company anticipates a 25% rise in drivers this year to exceed 500,000, follows a $160 million 2025 in…
Teva Pharmaceutical Industries Ltd. has announced a proposed acquisition of the novel dexmedetomidine sublingual film product, BXCL501, from BioXcel Therapeutics through a court-supervised sale process. The product is under FDA review for at-home treatment of agitation in adults with schizophrenia or bipolar disorder, potentially becoming the first…
Seven people charged over damage to U.S. President Donald Trump’s Turnberry golf resort in Scotland last year have been told prosecutors will seek tougher sentences because the alleged offences are ‘aggravated by reason of having a terrorist connection’. The charges relate to spray-painting of pro-Palestinian slogans, digging up greens and alleged …
A disagreement over whether certain cheese names are generic or reserved for European regional products has emerged as a complication in bilateral trade talks between the United States and Mexico. The row stems from a Mexico-EU deal that grants legal protections to dozens of European cheeses and may affect U.S. exporters who have long used generic …
Radiant World, a major global iron ore and base metals trading house founded by Pinkesh Nahar, is facing a wave of counterparty and banking actions after reports it submitted invalid documents to lenders. The firm denies the allegations. Multiple trading houses, banks and brokers have frozen accounts or stopped new business, and authorities in Sing…
Netcapital Inc. announced that it received a notification from Nasdaq for failing to timely file its Annual Report on Form 10-K for the fiscal year ended April 30, 2026. The company has 60 days to submit a plan to regain compliance and could be granted up to 180 days to file the report if Nasdaq accepts the plan. There is uncertainty whether the co…
Red Cross officials estimate at least 93,000 people have been directly affected by a Himalayan landslide and urgently require humanitarian assistance. Relief convoys were temporarily blocked after a lake formed by the landslide broke its banks, halting rescue operations. U.N. and World Health Organization spokespeople warned of ongoing cascading ha…
Nepal has declined offers from foreign governments to send search-and-rescue teams following a flash flood that swept through areas including Rasuwa district near the Chinese border. The disaster has levelled towns, damaged hydropower projects and killed close to 500 people. Hundreds of foreign nationals remain unaccounted for; South Korea has repo…
International Bancshares (IBOC) trades at a reasonable valuation with high free cash flow, low leverage and solid returns - a setup that supports a long trade targeting the 52-week high. The bank's asset-quality posture and capacity to generate free cash flow justify upside while the technicals show an oversold entry.
Jiayin Group Inc., a fintech platform listed on NASDAQ, reported a sharp decline in its Q2 2026 financial performance with a 74.4% drop in transaction volume to RMB9.5 billion and a net loss of RMB183.6 million compared to net income of RMB519.1 million in the same period last year. The company is transitioning its strategy from scale-driven growth…
Quoin Pharmaceuticals announced a private placement financing to raise up to $50 million, including upfront funding of approximately $30.8 million, aimed at supporting the completion of clinical development programs for rare and orphan disease therapies, particularly for Netherton Syndrome. The proceeds are expected to fund operations through mid-2…
Immuron Limited reported preliminary financial results for FY26, exceeding sales and profit projections with record A$7.7 million sales, driven by growth in Australia and the U.S. The company achieved key clinical milestones including FDA IND approval for IMM-529 and U.S. Department of Defense-funded research collaborations. Immuron plans to invest…
BioXcel Therapeutics announced its entry into a court-supervised Chapter 11 bankruptcy process and an asset sale agreement with Teva Pharmaceuticals, which will act as the stalking horse bidder for the company's assets, including its drug IGALMI®. The company secured $19 million in DIP financing to support ongoing operations during the bankruptcy p…
Quoin Pharmaceuticals announced positive interim results from its ongoing Phase 2/3 study evaluating QRX003 4% lotion in patients with Netherton Syndrome. The study showed that 66.7% of the first six patients achieved a significant improvement in skin condition after 12 weeks of treatment, meeting the trial's primary endpoint with statistical signi…
Cytokinetics announced positive top-line results from its ACACIA-HCM Phase 3 trial evaluating aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM). The trial met dual primary endpoints showing statistically significant improvements in patient-reported outcomes and exercise capacity compared to placebo. Based on these results,…
PayPal shares plunged in premarket trading after reports said a consortium including private equity and a payments processor had dropped its pursuit of the company. The consortium had previously been linked to a $60.50-per-share proposal. PayPal has been navigating a post-pandemic slowdown in digital payments and heightened competition while advanc…
Apollo has the balance sheet and deal flow to turn recent asset-gathering and financing platforms into sustained fee-related earnings. With market cap near $78.8B, strong free cash flow and a cleaner capital structure after a preferred conversion, the stock is set up for a rerating if realized performance fees and AUM mix shift in favor of recurrin…
Autodesk shares are trading lower in pre-market action after the company reported second-quarter fiscal 2027 results. While revenue and adjusted EPS topped expectations, management’s full-year profit midpoint landed slightly below consensus and near-term free cash flow is being reduced by acquisition-related costs tied to MaintainX. The market reac…
Amprius (AMPX) has fallen from a $24 high to the low-$10s despite stronger production signaling and a cleaner path to defense contracts. The stock now trades at a market cap of about $1.54B with stretched valuation metrics but improving fundamentals. This trade idea outlines a disciplined long with an entry at $10.50, stop at $7.00, and target at $…
INmune Bio (INMB) is a small-cap biotech where recent signs of UK regulatory alignment for the CORDStrom platform, plus continued positive readouts and FDA Fast Track for XPro1595 in Alzheimer’s, create a defined asymmetric trade. The balance sheet is tight, but the risk/reward supports a long trade sized for high volatility.
SEI (SEIC) is a capital-light, high-ROE investment-services platform benefiting from accelerated alternatives adoption and expanding outsourcing mandates. With $1.9 trillion in assets serviced, low leverage, solid free cash flow of $671M and a reasonable mid-teens EV/EBITDA multiple, we prefer a tactical long targeting $130 while managing risk with…
CDT Equity Inc. announced validation of new solid drug forms with improved physical properties such as stability and solubility, secured by patents in their intellectual property portfolio. These innovations enable tailored formulations for underserved patient groups and extend the commercial life of existing assets. By integrating AI-driven data a…
